Sigbert Jahn

发表

Rationale, design, and methods of a non-interventional study to establish safety, effectiveness, quality of life, cognition, health-related and work capacity data on Alemtuzumab in multiple sclerosis patients in Germany (TREAT-MS)

Raimar Kern, Tjalf Ziemssen, T. Ziemssen, 2016, BMC Neurology.